Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Neurogen reveals D3/D4 receptor-selective compounds

July 19, 1996

5-HT1A receptor-selective agents from American Home Products

July 19, 1996

Positive trial results of Janssen's sabeluzole in obstructive sleep apnea patients

July 19, 1996

5-HT1-like receptor agonists as migraine treatment from Merck & Co.

July 19, 1996

BTG-2403: representative opioid analgesic

July 19, 1996

Glaxo Wellcome's Ultiva receives FDA approval

July 19, 1996

NOS inhibitors from Merck & Co.

July 12, 1996

TNF research findings

July 12, 1996

Muscarinic receptor ligand selected for further study

July 12, 1996

First demonstration of cellular mechanism of human oral tolerance

July 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...